Radionetics Oncology Funding: $83M Raised, Series A (2024)
Radionetics Oncology is based in San Diego, California. It has raised $83M in total funding. Latest round: Series A.
Radionetics Oncology funding overview
Radionetics Oncology is based in San Diego, California. Radionetics Oncology has raised $83M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Radionetics Oncology runs through 2024; nothing later has been disclosed. Investors on record include Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, GordonMD Global Investments. 5 distinct backers are named across the disclosed rounds.
Radionetics Oncology at a glance
Total raised
$83M
Latest round
Series A
Latest round date
January 2024
Headquarters
San Diego, California
Notable investors
Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, GordonMD Global Investments
Frequently asked about Radionetics Oncology funding
How much has Radionetics Oncology raised?
Radionetics Oncology has raised $83M in total disclosed funding across the rounds on record.
Who has invested in Radionetics Oncology?
Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, GordonMD Global Investments are named among the investors backing Radionetics Oncology.
What was the latest Radionetics Oncology funding round?
The most recent disclosed round is a Series A, announced in January 2024.
Where is Radionetics Oncology based?
Radionetics Oncology is based in San Diego, California.
When did Radionetics Oncology last raise?
The last disclosed Radionetics Oncology round closed in January 2024 at Series A.
Totals shown for Radionetics Oncology aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.
